APO Research

APO RESEARCH · REPORT

Coccidiosis Vaccines in Chickens

Selected research

Market Structure

Global Coccidiosis Vaccines in Chickens Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Coccidiosis Vaccines in Chickens market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Coccidiosis Vaccines in Chickens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coccidiosis Vaccines in Chickens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coccidiosis Vaccines in Chickens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coccidiosis Vaccines in Chickens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coccidiosis Vaccines in Chickens include Biopharm, Bioproperties, Boehringer Ingelheim, Ceva Santé Animale, HIPRA, Huvepharma, MSD Animal Health, Nisseiken and Vaxxinova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coccidiosis Vaccines in Chickens market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coccidiosis Vaccines in Chickens and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coccidiosis Vaccines in Chickens sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coccidiosis Vaccines in Chickens market size, projected growth trends, production technologies, key applications, and end-use industries.

Coccidiosis Vaccines in Chickens Segment by Company

Biopharm

Bioproperties

Boehringer Ingelheim

Ceva Santé Animale

HIPRA

Huvepharma

MSD Animal Health

Nisseiken

Vaxxinova

Foshan Standard Biotech

Hlinte

Qilu Qingda Bio-Pharmaceutical

Skystar Bio-pharm

Guangdong Winsun Bio-pharmaceutical

Coccidiosis Vaccines in Chickens Segment by Type

Attenuated Vaccines

Non-attenuated Vaccines

Coccidiosis Vaccines in Chickens Segment by Application

Layers

Turkeys

Broilers

Breeders

Coccidiosis Vaccines in Chickens Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coccidiosis Vaccines in Chickens market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coccidiosis Vaccines in Chickens and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coccidiosis Vaccines in Chickens.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coccidiosis Vaccines in Chickens market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coccidiosis Vaccines in Chickens manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Coccidiosis Vaccines in Chickens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Coccidiosis Vaccines in Chickens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Coccidiosis Vaccines in Chickens Industry Trends Table 2. Coccidiosis Vaccines in Chickens Industry Drivers Table 3. Coccidiosis Vaccines in Chickens Industry Opportunities and Challenges Table 4. Coccidiosis Vaccines in Chickens Industry Restraints Table 5. Global Coccidiosis Vaccines in Chickens Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Coccidiosis Vaccines in Chickens Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Coccidiosis Vaccines in Chickens Sales Market Share by Manufacturers Table 9. Global Coccidiosis Vaccines in Chickens Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Coccidiosis Vaccines in Chickens Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Coccidiosis Vaccines in Chickens Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Coccidiosis Vaccines in Chickens Manufacturers, Product Type & Application Table 13. Global Coccidiosis Vaccines in Chickens Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Coccidiosis Vaccines in Chickens by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Attenuated Vaccines Table 17. Major Manufacturers of Non-attenuated Vaccines Table 18. Global Coccidiosis Vaccines in Chickens Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Coccidiosis Vaccines in Chickens Sales by Type (2021-2026) & (K Units) Table 20. Global Coccidiosis Vaccines in Chickens Sales by Type (2027-2032) & (K Units) Table 21. Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2021-2026) Table 22. Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2027-2032) Table 23. Global Coccidiosis Vaccines in Chickens Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Coccidiosis Vaccines in Chickens Revenue by Type (2021-2026) & (K Units) Table 25. Global Coccidiosis Vaccines in Chickens Revenue by Type (2027-2032) & (K Units) Table 26. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2021-2026) Table 27. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Layers Table 29. Major Manufacturers of Turkeys Table 30. Major Manufacturers of Broilers Table 31. Major Manufacturers of Breeders Table 32. Global Coccidiosis Vaccines in Chickens Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Coccidiosis Vaccines in Chickens Sales by Application (2021-2026) & (K Units) Table 34. Global Coccidiosis Vaccines in Chickens Sales by Application (2027-2032) & (K Units) Table 35. Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2021-2026) Table 36. Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2027-2032) Table 37. Global Coccidiosis Vaccines in Chickens Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Coccidiosis Vaccines in Chickens Revenue by Application (2021-2026) & (K Units) Table 39. Global Coccidiosis Vaccines in Chickens Revenue by Application (2027-2032) & (K Units) Table 40. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2021-2026) Table 41. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2027-2032) Table 42. Global Coccidiosis Vaccines in Chickens Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Coccidiosis Vaccines in Chickens Sales by Region (2021-2026) & (K Units) Table 44. Global Coccidiosis Vaccines in Chickens Sales Market Share by Region (2021-2026) Table 45. Global Coccidiosis Vaccines in Chickens Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Coccidiosis Vaccines in Chickens Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Coccidiosis Vaccines in Chickens Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 49. North America Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 50. Europe Coccidiosis Vaccines in Chickens Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 52. Europe Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Coccidiosis Vaccines in Chickens Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Coccidiosis Vaccines in Chickens Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 59. Global Coccidiosis Vaccines in Chickens Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Coccidiosis Vaccines in Chickens Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Coccidiosis Vaccines in Chickens Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Region (2021-2026) Table 63. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Region (2027-2032) Table 64. Biopharm Company Information Table 65. Biopharm Business Overview Table 66. Biopharm Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Biopharm Coccidiosis Vaccines in Chickens Product Portfolio Table 68. Biopharm Recent Development Table 69. Bioproperties Company Information Table 70. Bioproperties Business Overview Table 71. Bioproperties Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bioproperties Coccidiosis Vaccines in Chickens Product Portfolio Table 73. Bioproperties Recent Development Table 74. Boehringer Ingelheim Company Information Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Boehringer Ingelheim Coccidiosis Vaccines in Chickens Product Portfolio Table 78. Boehringer Ingelheim Recent Development Table 79. Ceva Santé Animale Company Information Table 80. Ceva Santé Animale Business Overview Table 81. Ceva Santé Animale Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ceva Santé Animale Coccidiosis Vaccines in Chickens Product Portfolio Table 83. Ceva Santé Animale Recent Development Table 84. HIPRA Company Information Table 85. HIPRA Business Overview Table 86. HIPRA Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. HIPRA Coccidiosis Vaccines in Chickens Product Portfolio Table 88. HIPRA Recent Development Table 89. Huvepharma Company Information Table 90. Huvepharma Business Overview Table 91. Huvepharma Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Huvepharma Coccidiosis Vaccines in Chickens Product Portfolio Table 93. Huvepharma Recent Development Table 94. MSD Animal Health Company Information Table 95. MSD Animal Health Business Overview Table 96. MSD Animal Health Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. MSD Animal Health Coccidiosis Vaccines in Chickens Product Portfolio Table 98. MSD Animal Health Recent Development Table 99. Nisseiken Company Information Table 100. Nisseiken Business Overview Table 101. Nisseiken Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Nisseiken Coccidiosis Vaccines in Chickens Product Portfolio Table 103. Nisseiken Recent Development Table 104. Vaxxinova Company Information Table 105. Vaxxinova Business Overview Table 106. Vaxxinova Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Vaxxinova Coccidiosis Vaccines in Chickens Product Portfolio Table 108. Vaxxinova Recent Development Table 109. Foshan Standard Biotech Company Information Table 110. Foshan Standard Biotech Business Overview Table 111. Foshan Standard Biotech Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Foshan Standard Biotech Coccidiosis Vaccines in Chickens Product Portfolio Table 113. Foshan Standard Biotech Recent Development Table 114. Hlinte Company Information Table 115. Hlinte Business Overview Table 116. Hlinte Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Hlinte Coccidiosis Vaccines in Chickens Product Portfolio Table 118. Hlinte Recent Development Table 119. Qilu Qingda Bio-Pharmaceutical Company Information Table 120. Qilu Qingda Bio-Pharmaceutical Business Overview Table 121. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio Table 123. Qilu Qingda Bio-Pharmaceutical Recent Development Table 124. Skystar Bio-pharm Company Information Table 125. Skystar Bio-pharm Business Overview Table 126. Skystar Bio-pharm Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Skystar Bio-pharm Coccidiosis Vaccines in Chickens Product Portfolio Table 128. Skystar Bio-pharm Recent Development Table 129. Guangdong Winsun Bio-pharmaceutical Company Information Table 130. Guangdong Winsun Bio-pharmaceutical Business Overview Table 131. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio Table 133. Guangdong Winsun Bio-pharmaceutical Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Coccidiosis Vaccines in Chickens Distributors List Table 137. Coccidiosis Vaccines in Chickens Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Coccidiosis Vaccines in Chickens Product Image Figure 2. Global Coccidiosis Vaccines in Chickens Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coccidiosis Vaccines in Chickens Market Size (2021-2032) & (US$ Million) Figure 4. Global Coccidiosis Vaccines in Chickens Sales (2021-2032) & (K Units) Figure 5. Global Coccidiosis Vaccines in Chickens Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Coccidiosis Vaccines in Chickens Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Attenuated Vaccines Image Figure 9. Non-attenuated Vaccines Image Figure 10. Global Coccidiosis Vaccines in Chickens Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Coccidiosis Vaccines in Chickens Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2021-2032) Figure 13. Global Coccidiosis Vaccines in Chickens Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Coccidiosis Vaccines in Chickens Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2021-2032) Figure 16. Layers Image Figure 17. Turkeys Image Figure 18. Broilers Image Figure 19. Breeders Image Figure 20. Global Coccidiosis Vaccines in Chickens Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Coccidiosis Vaccines in Chickens Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2021-2032) Figure 23. Global Coccidiosis Vaccines in Chickens Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Coccidiosis Vaccines in Chickens Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2021-2032) Figure 26. North America Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 28. U.S. Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 33. Germany Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 40. China Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 48. Brazil Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Coccidiosis Vaccines in Chickens Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Coccidiosis Vaccines in Chickens Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Coccidiosis Vaccines in Chickens Revenue (2021-2032) & (US$ Million) Figure 59. North America Coccidiosis Vaccines in Chickens Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Coccidiosis Vaccines in Chickens Revenue (2021-2032) & (US$ Million) Figure 61. Europe Coccidiosis Vaccines in Chickens Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Coccidiosis Vaccines in Chickens Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Coccidiosis Vaccines in Chickens Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Coccidiosis Vaccines in Chickens Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Coccidiosis Vaccines in Chickens Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Coccidiosis Vaccines in Chickens Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Coccidiosis Vaccines in Chickens Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Vaccines
  • Non-attenuated Vaccines
Applications
  • Layers
  • Turkeys
  • Broilers
  • Breeders
Companies covered
  • Biopharm
  • Bioproperties
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • HIPRA
  • Huvepharma
  • MSD Animal Health
  • Nisseiken
  • Vaxxinova
  • Foshan Standard Biotech
  • Hlinte
  • Qilu Qingda Bio-Pharmaceutical
  • Skystar Bio-pharm
  • Guangdong Winsun Bio-pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Coccidiosis Vaccines in Chickens Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Coccidiosis Vaccines in Chickens Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Coccidiosis Vaccines in Chickens Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Coccidiosis Vaccines in Chickens Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Coccidiosis Vaccines in Chickens Market Dynamics
  1. 2.1 Coccidiosis Vaccines in Chickens Industry Trends
  2. 2.2 Coccidiosis Vaccines in Chickens Industry Drivers
  3. 2.3 Coccidiosis Vaccines in Chickens Industry Opportunities and Challenges
  4. 2.4 Coccidiosis Vaccines in Chickens Industry Restraints
3 Coccidiosis Vaccines in Chickens Market by Manufacturers
  1. 3.1 Global Coccidiosis Vaccines in Chickens Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Coccidiosis Vaccines in Chickens Sales by Manufacturers (2021-2026)
  3. 3.3 Global Coccidiosis Vaccines in Chickens Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Coccidiosis Vaccines in Chickens Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coccidiosis Vaccines in Chickens Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Coccidiosis Vaccines in Chickens Manufacturers, Product Type & Application
  7. 3.7 Global Coccidiosis Vaccines in Chickens Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coccidiosis Vaccines in Chickens Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coccidiosis Vaccines in Chickens Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coccidiosis Vaccines in Chickens Tier 1, Tier 2, and Tier 3
4 Coccidiosis Vaccines in Chickens Market by Type
  1. 4.1 Coccidiosis Vaccines in Chickens Type Introduction
  2. 4.1.1 Attenuated Vaccines
  3. 4.1.2 Non-attenuated Vaccines
  4. 4.2 Global Coccidiosis Vaccines in Chickens Sales by Type
  5. 4.2.1 Global Coccidiosis Vaccines in Chickens Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Coccidiosis Vaccines in Chickens Sales by Type (2021-2032)
  7. 4.2.3 Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2021-2032)
  8. 4.3 Global Coccidiosis Vaccines in Chickens Revenue by Type
  9. 4.3.1 Global Coccidiosis Vaccines in Chickens Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Coccidiosis Vaccines in Chickens Revenue by Type (2021-2032)
  11. 4.3.3 Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2021-2032)
5 Coccidiosis Vaccines in Chickens Market by Application
  1. 5.1 Coccidiosis Vaccines in Chickens Application Introduction
  2. 5.1.1 Layers
  3. 5.1.2 Turkeys
  4. 5.1.3 Broilers
  5. 5.1.4 Breeders
  6. 5.2 Global Coccidiosis Vaccines in Chickens Sales by Application
  7. 5.2.1 Global Coccidiosis Vaccines in Chickens Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Coccidiosis Vaccines in Chickens Sales by Application (2021-2032)
  9. 5.2.3 Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2021-2032)
  10. 5.3 Global Coccidiosis Vaccines in Chickens Revenue by Application
  11. 5.3.1 Global Coccidiosis Vaccines in Chickens Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Coccidiosis Vaccines in Chickens Revenue by Application (2021-2032)
  13. 5.3.3 Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2021-2032)
6 Global Coccidiosis Vaccines in Chickens Sales by Region
  1. 6.1 Global Coccidiosis Vaccines in Chickens Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coccidiosis Vaccines in Chickens Sales by Region (2021-2032)
  3. 6.2.1 Global Coccidiosis Vaccines in Chickens Sales by Region (2021-2026)
  4. 6.2.2 Global Coccidiosis Vaccines in Chickens Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Coccidiosis Vaccines in Chickens Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Coccidiosis Vaccines in Chickens Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Coccidiosis Vaccines in Chickens Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Coccidiosis Vaccines in Chickens Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Coccidiosis Vaccines in Chickens Revenue by Region
  1. 7.1 Global Coccidiosis Vaccines in Chickens Revenue by Region
  2. 7.1.1 Global Coccidiosis Vaccines in Chickens Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Coccidiosis Vaccines in Chickens Revenue by Region (2021-2026)
  4. 7.1.3 Global Coccidiosis Vaccines in Chickens Revenue by Region (2027-2032)
  5. 7.1.4 Global Coccidiosis Vaccines in Chickens Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Coccidiosis Vaccines in Chickens Revenue (2021-2032)
  8. 7.2.2 North America Coccidiosis Vaccines in Chickens Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Coccidiosis Vaccines in Chickens Revenue (2021-2032)
  11. 7.3.2 Europe Coccidiosis Vaccines in Chickens Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Coccidiosis Vaccines in Chickens Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Coccidiosis Vaccines in Chickens Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Coccidiosis Vaccines in Chickens Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Coccidiosis Vaccines in Chickens Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biopharm
  2. 8.1.1 Biopharm Company Information
  3. 8.1.2 Biopharm Business Overview
  4. 8.1.3 Biopharm Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biopharm Coccidiosis Vaccines in Chickens Product Portfolio
  6. 8.1.5 Biopharm Recent Developments
  7. 8.2 Bioproperties
  8. 8.2.1 Bioproperties Company Information
  9. 8.2.2 Bioproperties Business Overview
  10. 8.2.3 Bioproperties Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bioproperties Coccidiosis Vaccines in Chickens Product Portfolio
  12. 8.2.5 Bioproperties Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Coccidiosis Vaccines in Chickens Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Ceva Santé Animale
  20. 8.4.1 Ceva Santé Animale Company Information
  21. 8.4.2 Ceva Santé Animale Business Overview
  22. 8.4.3 Ceva Santé Animale Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Santé Animale Coccidiosis Vaccines in Chickens Product Portfolio
  24. 8.4.5 Ceva Santé Animale Recent Developments
  25. 8.5 HIPRA
  26. 8.5.1 HIPRA Company Information
  27. 8.5.2 HIPRA Business Overview
  28. 8.5.3 HIPRA Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HIPRA Coccidiosis Vaccines in Chickens Product Portfolio
  30. 8.5.5 HIPRA Recent Developments
  31. 8.6 Huvepharma
  32. 8.6.1 Huvepharma Company Information
  33. 8.6.2 Huvepharma Business Overview
  34. 8.6.3 Huvepharma Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Huvepharma Coccidiosis Vaccines in Chickens Product Portfolio
  36. 8.6.5 Huvepharma Recent Developments
  37. 8.7 MSD Animal Health
  38. 8.7.1 MSD Animal Health Company Information
  39. 8.7.2 MSD Animal Health Business Overview
  40. 8.7.3 MSD Animal Health Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MSD Animal Health Coccidiosis Vaccines in Chickens Product Portfolio
  42. 8.7.5 MSD Animal Health Recent Developments
  43. 8.8 Nisseiken
  44. 8.8.1 Nisseiken Company Information
  45. 8.8.2 Nisseiken Business Overview
  46. 8.8.3 Nisseiken Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nisseiken Coccidiosis Vaccines in Chickens Product Portfolio
  48. 8.8.5 Nisseiken Recent Developments
  49. 8.9 Vaxxinova
  50. 8.9.1 Vaxxinova Company Information
  51. 8.9.2 Vaxxinova Business Overview
  52. 8.9.3 Vaxxinova Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vaxxinova Coccidiosis Vaccines in Chickens Product Portfolio
  54. 8.9.5 Vaxxinova Recent Developments
  55. 8.10 Foshan Standard Biotech
  56. 8.10.1 Foshan Standard Biotech Company Information
  57. 8.10.2 Foshan Standard Biotech Business Overview
  58. 8.10.3 Foshan Standard Biotech Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Foshan Standard Biotech Coccidiosis Vaccines in Chickens Product Portfolio
  60. 8.10.5 Foshan Standard Biotech Recent Developments
  61. 8.11 Hlinte
  62. 8.11.1 Hlinte Company Information
  63. 8.11.2 Hlinte Business Overview
  64. 8.11.3 Hlinte Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hlinte Coccidiosis Vaccines in Chickens Product Portfolio
  66. 8.11.5 Hlinte Recent Developments
  67. 8.12 Qilu Qingda Bio-Pharmaceutical
  68. 8.12.1 Qilu Qingda Bio-Pharmaceutical Company Information
  69. 8.12.2 Qilu Qingda Bio-Pharmaceutical Business Overview
  70. 8.12.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio
  72. 8.12.5 Qilu Qingda Bio-Pharmaceutical Recent Developments
  73. 8.13 Skystar Bio-pharm
  74. 8.13.1 Skystar Bio-pharm Company Information
  75. 8.13.2 Skystar Bio-pharm Business Overview
  76. 8.13.3 Skystar Bio-pharm Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Skystar Bio-pharm Coccidiosis Vaccines in Chickens Product Portfolio
  78. 8.13.5 Skystar Bio-pharm Recent Developments
  79. 8.14 Guangdong Winsun Bio-pharmaceutical
  80. 8.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
  81. 8.14.2 Guangdong Winsun Bio-pharmaceutical Business Overview
  82. 8.14.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio
  84. 8.14.5 Guangdong Winsun Bio-pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coccidiosis Vaccines in Chickens Value Chain Analysis
  2. 9.1.1 Coccidiosis Vaccines in Chickens Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coccidiosis Vaccines in Chickens Production Mode & Process
  6. 9.2 Coccidiosis Vaccines in Chickens Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coccidiosis Vaccines in Chickens Distributors
  9. 9.2.3 Coccidiosis Vaccines in Chickens Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research